SUPPLEMENT

Q2 2023 — Income statement trends

Q2 2023PDF · 2 pages143 KB
CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q221 	Q321 	Q421 	Q122 	Q222 	Q322 	Q422 	Q123 	Q223
Revenues:
Clearing and transaction fees 	929.9 	878.9 	949.3 	1,138.1 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3
Market data and information services 	145.2 	145.4 	142.1 	151.7 	151.7 	154.3 	153.2 	165.8 	163.1
Other Revenue 	104.1 	85.6 	55.9 	56.8 	60.9 	74.9 	73.2 	75.6 	78.8
Total revenues 	1,179.2 	1,109.9 	1,147.3 	1,346.6 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2
Expenses:
Compensation and benefits 	211.7 	198.6 	201.7 	185.2 	185.3 	189.6 	193.0 	204.5 	205.7
Technology 	49.3 	49.3 	45.8 	45.9 	45.9 	46.8 	50.0 	51.3 	53.3
Professional fees and outside services 	36.8 	45.2 	32.3 	31.8 	32.0 	35.1 	38.5 	38.3 	37.8
Amortization of purchased intangibles 	59.4 	59.0 	58.6 	58.4 	57.1 	55.5 	56.7 	56.8 	57.0
Depreciation and amortization 	37.1 	37.2 	35.9 	33.5 	33.0 	34.5 	33.9 	31.9 	32.3
Licensing and other fee agreements 	54.2 	57.6 	60.4 	80.9 	83.1 	83.6 	72.4 	84.7 	78.2
Other expense 	56.0 	49.3 	80.9 	51.8 	51.1 	43.9 	95.0 	60.4 	57.3
Operating expenses 	504.5 	496.2 	515.6 	487.5 	487.5 	489.0 	539.5 	527.9 	521.6
Operating Income 	674.7 	613.7 	631.7 	859.1 	749.7 	738.8 	668.3 	913.7 	838.6
Operating Margin 	57% 	55% 	55% 	64% 	61% 	60% 	55% 	63% 	62%
Non-operating Income and Expense
Investment income 	62.4 	145.8 	67.8 	73.1 	286.9 	686.2 	1,152.2 	1,357.7 	1,568.2
Interest and other borrowing costs 	(41.7) 	(41.8) 	(41.9) 	(42.5) 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2)
Equity in net gains (losses) of unconsolidated subsidiaries 	55.7 	66.4 	67.5 	73.3 	87.3 	76.5 	64.0 	78.2 	75.1
Other non-operating income (expense) 	(25.0) 	311.8 	74.2 	(46.7) 	(217.3) 	(581.1) 	(1,017.3) 	(1,152.8) 	(1,425.3)
Non-operating income (expense) 	51.4 	482.2 	167.6 	57.2 	117.0 	141.2 	159.0 	243.2 	177.8
Income before income taxes 	726.1 	1,095.9 	799.3 	916.3 	866.7 	880.0 	827.3 	1,156.9 	1,016.4
Income taxes 	215.5 	169.6 	174.1 	205.3 	204.2 	200.4 	189.4 	273.1 	238.8
Net income 	510.6 	926.3 	625.2 	711.0 	662.5 	679.6 	637.9 	883.8 	777.6
Less: net income (loss) attributable to NCI 	0.3 	(0.2) 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	510.3 	926.5 	625.2 	711.0 	662.5 	679.6 	637.9 	883.8 	777.6
Net Income Attributable to Common Shareholders of CME Group 	510.3 	926.5 	613.3 	702.0 	654.1 	671.1 	629.9 	872.7 	767.8
Effective Tax Rate 	29.7% 	15.5% 	21.8% 	22.4% 	23.6% 	22.8% 	22.8% 	23.6% 	23.5%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.42 	2.59 	1.71 	1.96 	1.82 	1.87 	1.76 	2.43 	2.14
Diluted EPS 	1.42 	2.58 	1.71 	1.95 	1.82 	1.87 	1.75 	2.43 	2.14
Weighted average number of common stock shares:
Basic Shares 	358,261 	358,363 	358,582 	358,609 	358,641 	358,715 	358,885 	358,933 	358,940
Diluted Shares 	358,888 	358,988 	359,019 	359,180 	359,205 	359,288 	359,190 	359,313 	359,429
Preferred Shares 	2,890 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 1 of 2 --

CME GROUP INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF NON-GAAP INCOME
QUARTER ENDED
(dollars in millions, except per share data; shares in thousands)
Q221 	Q321 	Q421 	Q122 	Q222 	Q322 	Q422 	Q123 	Q223
Revenues:
Clearing and transaction fees 	929.9 	878.9 	949.3 	1,138.1 	1,024.6 	998.6 	981.4 	1,200.2 	1,118.3
Market data and information services 	145.2 	145.4 	142.1 	151.7 	151.7 	154.3 	153.2 	165.8 	163.1
Other Revenue 	101.0 	85.6 	55.9 	56.8 	60.9 	74.9 	73.2 	75.6 	78.8
Total revenues 	1,176.1 	1,109.9 	1,147.3 	1,346.6 	1,237.2 	1,227.8 	1,207.8 	1,441.6 	1,360.2
Expenses:
Compensation and benefits 	201.9 	191.1 	183.7 	182.8 	189.5 	189.1 	184.6 	192.8 	194.4
Technology 	49.2 	49.1 	45.6 	45.8 	45.9 	46.8 	50.0 	51.3 	53.3
Professional fees and outside services 	30.0 	26.5 	27.2 	30.3 	31.4 	35.1 	38.5 	38.3 	37.8
Amortization of purchased intangibles 	- 	- 	- 	- 	- 	- 	- 	- 	-
Depreciation and amortization 	36.7 	36.7 	35.6 	33.5 	32.9 	33.8 	33.9 	31.9 	31.8
Licensing and other fee agreements 	54.2 	57.6 	60.4 	80.9 	83.1 	81.9 	72.4 	84.7 	78.2
Other expense 	54.8 	51.3 	76.5 	51.7 	59.6 	54.4 	84.5 	59.7 	56.2
Operating expenses 	426.8 	412.3 	429.0 	425.0 	442.4 	441.1 	463.9 	458.7 	451.7
Operating Income 	749.3 	697.6 	718.3 	921.6 	794.8 	786.7 	743.9 	982.9 	908.5
Operating Margin 	64% 	63% 	63% 	68% 	64% 	64% 	62% 	68% 	67%
Non-operating Income and Expense
Investment income 	37.3 	55.1 	58.2 	74.7 	299.5 	688.5 	1,147.1 	1,277.5 	1,564.0
Interest and other borrowing costs 	(41.7) 	(41.8) 	(41.9) 	(42.5) 	(39.9) 	(40.4) 	(39.9) 	(39.9) 	(40.2)
Equity in net gains (losses) of unconsolidated subsidiaries 	55.7 	70.5 	78.7 	84.7 	98.2 	89.6 	76.2 	91.5 	88.6
Other non-operating income (expense) 	(25.0) 	(32.9) 	(33.0) 	(43.4) 	(218.5) 	(585.7) 	(1,023.3) 	(1,160.6) 	(1,429.9)
Non-operating income (expense) 	26.3 	50.9 	62.0 	73.5 	139.3 	152.0 	160.1 	168.5 	182.5
Income before income taxes 	775.6 	748.5 	780.3 	995.1 	934.1 	938.7 	904.0 	1,151.4 	1,091.0
Income taxes 	186.7 	174.3 	172.8 	228.9 	217.6 	219.6 	206.0 	269.1 	254.6
Net income 	588.9 	574.2 	607.5 	766.2 	716.5 	719.1 	698.0 	882.3 	836.4
Less: net income (loss) attributable to NCI 	0.3 	(0.2) 	- 	- 	- 	- 	- 	- 	-
Net Income Attributable to CME Group 	588.6 	574.4 	607.5 	766.2 	716.5 	719.1 	698.0 	882.3 	836.4
Net Income Attributable to Common Shareholders of CME Group 	588.6 	574.4 	595.7 	756.6 	707.5 	710.0 	689.1 	871.1 	825.9
Effective Tax Rate 	24.1% 	23.3% 	22.1% 	23.0% 	23.3% 	23.4% 	22.8% 	23.4% 	23.3%
Earnings per Share Attributable to Common Shareholders of CME Group:
Basic EPS 	1.64 	1.60 	1.66 	2.11 	1.97 	1.98 	1.92 	2.43 	2.30
Diluted EPS 	1.64 	1.60 	1.66 	2.11 	1.97 	1.98 	1.92 	2.42 	2.30
Weighted average number of common stock shares:
Basic Shares 	358,261 	358,363 	358,582 	358,609 	358,641 	358,715 	358,885 	358,933 	358,940
Diluted Shares 	358,888 	358,988 	359,019 	359,180 	359,205 	359,288 	359,190 	359,313 	359,429
Preferred Shares 	- 	- 	2,890 	4,584 	4,584 	4,584 	4,584 	4,584 	4,584

-- 2 of 2 --